Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
β-?[[[4,?5-Dihydro-?5-?[2-?(1H-?imidazol-?2-?ylamino)?ethyl]?-?3-?isoxazolyl]?carbonyl]?amino]?-?3,?4-?dihydro-?γ-?oxo-2(1H)?-?Isoquinolinebutanoic Acid is a derivative of isoxazole potentially used as integrin receptor antagonist.